The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage

BACKGROUND: FTY720 (Fingolimod) is a novel immunosuppressive drug investigated in clinical trials for organ transplantation and multiple sclerosis. It acts as a functional sphingosine-1-phosphate (S1P) receptor antagonist, thereby inhibiting the egress of lymphocytes from secondary lymphoid organs....

Descripción completa

Detalles Bibliográficos
Autores principales: Stradner, Martin H, Angerer, Hannes, Ortner, Thomas, Fuerst, Florentine C, Setznagl, Daniela, Kremser, Marie-Luise, Hermann, Josef, Graninger, Winfried B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258222/
https://www.ncbi.nlm.nih.gov/pubmed/22151889
http://dx.doi.org/10.1186/1471-2474-12-279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258222/
https://www.ncbi.nlm.nih.gov/pubmed/22151889
http://dx.doi.org/10.1186/1471-2474-12-279

Ejemplares similares